Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of pharmacogenetics as predictive biomarkers of response and/or toxicity in the treatment of colorectal cancer.

Clinical colorectal cancer - 1 Jan 2009

Bhushan Shriya, McLeod Howard, Walko Christine M

Abstract excerpt

Predicting response and limiting drug-induced toxicity are 2 important challenges faced by clinicians in the treatment of colorectal cancer (CRC). The introduction of genetic testing to individualize treatment regimens will hopefully allow better response prediction and limit drug-induced toxicity leading to improved patient outcomes. This review discusses the role of the predictive genetic tests associated with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Camptothecin
Share to Fluorouracil

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, ras

Share to Irinotecan

Share to Organoplatinum Compounds

Share to Oxaliplatin

Share to Pharmacogenetics

Source

Identifiers

PMID: 19203892
DOI: 10.3816/CCC.2009.n.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of pharmacogenetics as predictive biomarkers of response and/or toxicity in the treatment of colorectal cancer.PMID 19203892Read ↗

The role of pharmacogenetics in the new ESMO colorectal cancer guidelines.Semantic proximity Read ↗

Pharmacogenomics in colorectal cancer: The first step for individualized-therapySemantic proximity Read ↗

Recent advances in personalized colorectal cancer research.Semantic proximity Read ↗

Biomarker-based prediction of response to therapy for colorectal cancer: current perspective.Semantic proximity Read ↗

Predictive Biomarkers in Colorectal Cancer: From the Single Therapeutic Target to a Plethora of Options.Semantic proximity Read ↗

Pharmacogenetics and pharmacogenomics of anticancer agents.Semantic proximity Read ↗

Application of pharmacogenetics in oncologySemantic proximity Read ↗

Pharmacogenetics of Anticancer Drug Sensitivity and Toxicity in Colorectal Cancer.Semantic proximity Read ↗

Overview of predictive and prognostic biomarkers and their importance in developing a clinical pharmacology treatment plan in colorectal cancer patients.Semantic proximity Read ↗

FOLFOX/FOLFIRI pharmacogenetics: the call for a personalized approach in colorectal cancer therapy.Semantic proximity Read ↗

Germline pharmacogenomics in oncology: decoding the patient for targeting therapy.Semantic proximity Read ↗

Actionable Potentials of Less Frequently Mutated Genes in Colorectal Cancer and Their Roles in Precision Medicine.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.